Phase
Condition
Anxiety Disorders
Depression
Cancer Treatment
Treatment
Promoting Resilience in Stress Management Program
Clinical Study ID
Ages 18-30 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria for Participants:
18-30 years of age
Speak and comprehend English sufficiently to be able to complete study proceduresand participate in the program in English
Have been diagnosed with cancer or desmoid tumor at least 6 or more weeks ago
Currently receiving treatment with curative intent or has completed treatment withcurative intent for cancer or desmoid tumor no more than 6 months ago
Score 10-14 on the PHQ-9 (Kroenke et al., 1999) or/and score 10-14 on the GAD-7 (Spitzer et al., 2006) during the initial screening assessment.
Exclusion
Participant Exclusion Criteria:
Adults unable to consent, individuals who are not yet adults (age <18), pregnantwomen, and prisoners.
Individuals who score <10 on both PHQ-9 and GAD-7.
Patients who score >14 (indicating moderately severe or severe depressive and/oranxiety symptoms) on PHQ-9 and/or GAD-7 will be ineligible for the current study butwill be offered a referral to an appropriate mental health provider for support, ifdesired.
Individuals who are treated with palliative intent for their disease, those who arediagnosed with cancer less than 6 weeks at the time of screening (we will be able toapproach them again after 6 weeks since diagnosis has passed), or those whocompleted treatment more than 6 months ago will also be ineligible for this study;they will be offered resources for support, if desired.
Individuals who report any suicidality (ideation, plan, and/or intent) at the timeof the eligibility screening will also be excluded from the current study, and theappropriate safety measures and/or referral to a mental health provider will bemade.
Inclusion Criteria for Support Person:
-≥ 18 years of age
-A friend or family member invited by the study participant to join the 6th PRISM session
Study Design
Study Description
Connect with a study center
Dana-Farber Cancer Institute
Boston, Massachusetts 02215
United StatesSite Not Available
Dana-Farber Cancer Institute
Brighton, Massachusetts 02135
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.